市場調查報告書
商品編碼
1029251

全球伴隨診斷市場:行業趨勢、市場份額、市場規模、增長、機會、預測(2021-2026)

Companion Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日期: | 出版商: IMARC Services Private Limited | 英文 146 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球伴隨診斷市場規模從 2015 年到 2020 年呈現強勁增長。展望未來,市場預計在 2021 年至 2026 年間以 19.5% 的複合年增長率增長。

癌症患病率的增加以及對體外診斷和靶向治療的需求不斷增加是推動全球伴隨診斷市場增長的關鍵因素之一。個性化醫療 (PHC) 和精準醫療在心血管、神經系統、傳染病和炎症疾病的治療中也很普遍,這些疾病正在推動市場增長。

此外,對下一代測序儀 (NGS) 需求的增加、臨床試驗數量的增加以及對藥物和診斷技術聯合開發的日益關注正在促進市場的增長。此外,新生物標誌物的引入、伴隨診斷的批准增加以及公司之間加強合作開發新的伴隨診斷也對市場增長產生積極影響。

本報告調查了全球伴隨診斷市場,並提供了全面的信息,包括市場概況、市場分析、價格分析、競爭格局和公司概況。

目錄

第一章前言

第二章範圍和調查方法

第 3 章執行摘要

第 4 章介紹

第 5 章全球伴隨診斷市場

  • 市場概覽
  • 市場表現
  • COVID-19 的影響

第 6 章市場細分:按產品和服務

  • 檢測、試劑盒、試劑
  • 軟件和服務

第 7 章市場細分:按技術

  • 免疫組織化學 (IHC)
  • 聚合□鏈反應 (PCR)
  • 原位雜交 (ISH)
  • 實時螢光定量 PCR (RT-PCR)
  • 基因測序
  • 其他

第 8 章市場細分:按指示

  • 癌症
    • 主要類型
  • 神經系統疾病
  • 傳染病
  • 心血管疾病
  • 其他

第 9 章市場細分:按最終用戶

  • 製藥和生物製藥公司
  • 參考實驗室
  • 委託研究機構
  • 其他

第 10 章市場細分:按地區

  • 北美
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳大利亞
    • 印度尼西亞
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場細分:按國家/地區

第11章SWOT分析

第十二章價值鏈分析

第十三章波特五力分析

第14章價格分析

第15章競爭形勢

  • 市場結構
  • 主要公司
  • 主要公司簡介
    • Abbott Laboratories
    • Agilent Technologies
    • BioMerieux
    • Danaher Corporation
    • Roche Holding AG
    • Myriad Genetics Inc.
    • Siemens Healthcare
    • Thermo Fisher Scientific Inc.
目錄
Product Code: SR1020F201_Report

The global companion diagnostics market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 19.5% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Companion diagnostics refer to a combination of tests and therapies that provide essential information about corresponding therapeutic products to deliver safe and effective medical care. These diagnostics also offer an in-depth understanding of disease biology and the mechanism of action (MOA), which help healthcare professionals determine the potential side effects or risks of a therapeutic product on the patient. At present, companion diagnostics are extensively utilized in oncology to deliver targeted therapies and personalized medicines to patients.

The growing prevalence of cancer, in confluence with the escalating demand for in-vitro diagnostics and targeted therapies, represents one of the key factors impelling the global companion diagnostics market growth. Apart from this, personalized healthcare (PHC) and precision medicine are also gaining traction in the treatment of cardiovascular, neurological, infectious and inflammatory diseases, which, in turn, is bolstering the growth of the market. Furthermore, the escalating demand for next-generation sequencing (NGS), the rising number of clinical trials and the increasing focus on the co-development of drugs and diagnostic technologies are contributing to the market growth. The introduction of new biomarkers, rising approvals of companion diagnostics and increasing collaboration between companies to develop novel companion diagnostic products are some of the other factors positively influencing the market growth. Currently, due to the spread of the coronavirus disease (COVID-19), diagnostic service providers are providing test services to healthcare providers. They are also utilizing companion diagnostics to detect the efficacy of COVID-19 drugs among patients undergoing oncology therapies.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global companion diagnostics market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product & services, technology, indication and end-user.

Breakup by Product & Service:

  • Assays, Kits and Reagents
  • Software and Services

Breakup by Technology:

  • Immunohistochemistry (IHC)
  • Polymerase Chain Reaction (PCR)
  • In-situ Hybridization (ISH)
  • Real-time PCR (RT-PCR)
  • Gene Sequencing
  • Others

Breakup by Indication:

  • Cancer
  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • Neurological Diseases
  • Infectious Diseases
  • Cardiovascular Diseases
  • Others

Breakup by End User:

  • Pharmaceutical & Biopharmaceutical Companies
  • Reference Laboratories
  • Contract Research Organizations
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Agilent Technologies, BioMerieux, Danaher Corporation, Roche Holding AG, Myriad Genetics Inc., Siemens Healthcare and Thermo Fisher Scientific Inc.

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Companion Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product & Service

  • 6.1 Assays, Kits and Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Software and Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Immunohistochemistry (IHC)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Polymerase Chain Reaction (PCR)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 In-situ Hybridization (ISH)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Real-time PCR (RT-PCR)
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Gene Sequencing
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Indication

  • 8.1 Cancer
    • 8.1.1 Market Trends
    • 8.1.2 Major Types
      • 8.1.2.1 Lung Cancer
      • 8.1.2.2 Breast Cancer
      • 8.1.2.3 Colorectal Cancer
      • 8.1.2.4 Gastric Cancer
      • 8.1.2.5 Melanoma
      • 8.1.2.6 Others
    • 8.1.3 Market Forecast
  • 8.2 Neurological Diseases
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Infectious Diseases
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cardiovascular Diseases
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pharmaceutical & Biopharmaceutical Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Reference Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Contract Research Organizations
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Agilent Technologies
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 BioMerieux
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Danaher Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Roche Holding AG
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 SWOT Analysis
    • 15.3.6 Myriad Genetics Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Siemens Healthcare
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Thermo Fisher Scientific Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Companion Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Companion Diagnostics Market: Sales Value (in Billion US$), 2015-2020
  • Figure 3: Global: Companion Diagnostics Market: Breakup by Product & Service (in %), 2020
  • Figure 4: Global: Companion Diagnostics Market: Breakup by Technology (in %), 2020
  • Figure 5: Global: Companion Diagnostics Market: Breakup by Indication (in %), 2020
  • Figure 6: Global: Companion Diagnostics Market: Breakup by End User (in %), 2020
  • Figure 7: Global: Companion Diagnostics Market: Breakup by Region (in %), 2020
  • Figure 8: Global: Companion Diagnostics Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 9: Global: Companion Diagnostics (Assays, Kits and Reagents) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 10: Global: Companion Diagnostics (Assays, Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 11: Global: Companion Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 12: Global: Companion Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 13: Global: Companion Diagnostics (Immunohistochemistry) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 14: Global: Companion Diagnostics (Immunohistochemistry) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 15: Global: Companion Diagnostics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 16: Global: Companion Diagnostics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 17: Global: Companion Diagnostics (In-situ Hybridization) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 18: Global: Companion Diagnostics (In-situ Hybridization) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 19: Global: Companion Diagnostics (Real-time PCR) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 20: Global: Companion Diagnostics (Real-time PCR) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 21: Global: Companion Diagnostics (Gene Sequencing) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 22: Global: Companion Diagnostics (Gene Sequencing) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 23: Global: Companion Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 24: Global: Companion Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 25: Global: Companion Diagnostics (Cancer) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 26: Global: Companion Diagnostics (Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 27: Global: Companion Diagnostics (Neurological Diseases) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 28: Global: Companion Diagnostics (Neurological Diseases) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 29: Global: Companion Diagnostics (Infectious Diseases) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 30: Global: Companion Diagnostics (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 31: Global: Companion Diagnostics (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 32: Global: Companion Diagnostics (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 33: Global: Companion Diagnostics (Other Indications) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 34: Global: Companion Diagnostics (Other Indications) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 35: Global: Companion Diagnostics (Pharmaceutical & Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 36: Global: Companion Diagnostics (Pharmaceutical & Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 37: Global: Companion Diagnostics (Reference Laboratories) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 38: Global: Companion Diagnostics (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 39: Global: Companion Diagnostics (Contract Research Organizations) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 40: Global: Companion Diagnostics (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 41: Global: Companion Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 42: Global: Companion Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 43: North America: Companion Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 44: North America: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 45: United States: Companion Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 46: United States: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 47: Canada: Companion Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 48: Canada: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 49: Asia Pacific: Companion Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 50: Asia Pacific: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 51: China: Companion Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 52: China: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 53: Japan: Companion Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 54: Japan: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 55: India: Companion Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 56: India: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 57: South Korea: Companion Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 58: South Korea: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 59: Australia: Companion Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 60: Australia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 61: Indonesia: Companion Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 62: Indonesia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 63: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 64: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 65: Europe: Companion Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 66: Europe: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 67: Germany: Companion Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 68: Germany: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 69: France: Companion Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 70: France: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 71: United Kingdom: Companion Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 72: United Kingdom: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 73: Italy: Companion Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 74: Italy: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 75: Spain: Companion Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 76: Spain: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 77: Russia: Companion Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 78: Russia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 79: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 80: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 81: Latin America: Companion Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 82: Latin America: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 83: Brazil: Companion Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 84: Brazil: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 85: Mexico: Companion Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 86: Mexico: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 87: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 88: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 89: Middle East and Africa: Companion Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 90: Middle East and Africa: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 91: Global: Companion Diagnostics Industry: SWOT Analysis
  • Figure 92: Global: Companion Diagnostics Industry: Value Chain Analysis
  • Figure 93: Global: Companion Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Companion Diagnostics Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Companion Diagnostics Market Forecast: Breakup by Product & Service (in Million US$), 2021-2026
  • Table 3: Global: Companion Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2021-2026
  • Table 4: Global: Companion Diagnostics Market Forecast: Breakup by Indication (in Million US$), 2021-2026
  • Table 5: Global: Companion Diagnostics Market Forecast: Breakup by End User (in Million US$), 2021-2026
  • Table 6: Global: Companion Diagnostics Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 7: Global: Companion Diagnostics Market Structure
  • Table 8: Global: Companion Diagnostics Market: Key Players